3-Amino-5-bromo-4-methoxy-benzoic acid methyl ester, 98.0%, 5g

Objectif Plan PLi S60x/0,85 IOS corrigé à l'infini

Sanilvudine, 95.0%, 100g

METHYL REL-(1R,3S)-3-{[(TERT-BUTOXY)CARBONYL]AMINO-1-METHYLCYCLOBUTANE-1-CARBOXYLATE, 95.0%, 1g

6-Chloro-4-methoxypyridazin-3(2H)-one, 98%, 100mg

5-Fluoro-2-methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 250mg

5-(2,5-Dimethylphenyl)-3-hydrazino-1,2,4-triazine, 95.0%, 5g

Methyl pyrazolo[1,5-a]pyrimidine-2-carboxylate, 97%, 100mg

2-(3-Cyano-4,5,5-trimethylfuran-2(5H)-ylidene)malononitrile, 97%, 5g

2,4-Dichloro-6-(trifluoromethyl)quinazoline, 95.0%, 250mg

N-(2-aminoethyl)nicotinamide dihydrochloride, 95.0%, 250mg

5-Bromo-1-methyl-4-nitro-1H-pyrazole, 95.0%, 10g

3-(Benzyloxy)-6-chloropyridazine, 95.0%, 1g